Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects.

Background: A once-daily (o.d.) fixed-dose combination of indacaterol acetate (IND), glycopyrronium bromide (GLY), and mometasone furoate (MF) delivered via the Breezhaler® device (IND/GLY/MF) is being developed for treatment of asthma. This study compared steady-state pharmacokinetics of IND, GLY a...

Descripción completa

Detalles Bibliográficos

Publicado en:	BMC Pulmonary Medicine Vol. 21; no. 1; pp. 1 - 13
Autores principales:	Inoue, Satoru, Vaidya, Soniya, Tillmann, Hanns-Christian, Sakita, Yohei, Machineni, Surendra, Heudi, Olivier, Furihata, Kenichi
Formato:	clinical trial research tables/charts Journal Article
Publicado:	BioMed Central 1/7/2021
Acceso en línea:	Ver este registro en EBSCOhost